More than a nosebleed
What you need to know before exploring more about HHT is that if you are an individual looking for additional information or a clinician wanting to learn more for a patient we always recommend that you contact your national HHT Center of expertise for the best answers and care possible. If you are unable to reach or find a Center our National Member Organizations will be happy to assist you. If you have no HHT Organization in your country please contact HHT Europe and we will offer you all the necessary assistance.
What is HHT?
Hereditary Haemorrhagic Telangiectasia is a rare genetic disorder of the blood vessels. It causes ArterioVenous Malformations (AVMs) in many vital organs.
Symptoms and obvious signs
90% of HHT patients suffer recurrent nosebleeds, which may result in anaemia and the need for
iron infusions and blood transfusions. These are small AVMs and appear like tiny red dots on the face, skin, lips, mouth and fingertips. (Other symptoms may include shortness of breath,
exercise intolerance, fatigue, migraine headaches, seizures, abdominal pain, intestinal bleeding)
The manifestations of HHT are variable; patients can present with a varied combination of symptoms and signs.
Screening for Pulmonary (lung) and Cerebral (brain) AVMs is essential to detect and treat when necessary and avoid a serious danger for patients during their entire life.
Possible lung and brain AVMs at birth.
Nosebleeds may begin. They can appear earlier, later or never at all.
Age 30 to 60
Telangiectases become more evident. Increase in nosebleeds. Possible increase in gastrointestinal bleeding.
Gastrointestinal bleeding may worsen. The dependence on iron infusions and blood transfusions may increase.
A diagnosis is likely if 3 of these clinical criteria are present:
- Spontaneous & recurrent nosebleeds.
- Multiple telangiectases in typical locations (face, lips, oral cavity, fingers)
- AVMs in other organs (lungs, liver, brain, gastrointestinal tract)
- A 1st degree relative with HHT by these criteria.